BetterLife Pharma Inc. SEC filings BETRF
BetterLife Pharma Inc. has 244 filings in SEC EDGAR's recent list, going back to Aug 7, 2009. Its latest annual report, Form 20-F, was filed on Jun 1, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 17, 2019, covering the quarter ended Apr 30, 2019. The most recent current report (Form 6-K) was filed on Sep 30, 2026. The company's fiscal year ends on January 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Feb 19, 2019 | Feb 15, 2019 |
| DEF 14A | Proxy statement | Oct 27, 2017 | Oct 24, 2017 |
| DEF 14A | Proxy statement | Nov 28, 2016 | Nov 28, 2016 |
| DEF 14A | Proxy statement | Nov 25, 2015 | Dec 30, 2015 |
| PRE 14A | Preliminary proxy statement | Aug 8, 2014 | Aug 8, 2014 |
| DEF 14A | Proxy statement | Apr 30, 2014 | Apr 28, 2014 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2014 | Apr 1, 2014 |
Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BETRF (OTC)
- Fiscal year ends
- January 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1464165
- Former names
- Pivot Pharmaceuticals Inc. (until Dec 3, 2019); Neurokine Pharmaceuticals Inc. (until Mar 26, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.